Post-Authorisation Active Safety Surveillance Program Among Patients Treated With Tofacitinib for Polyarticular Juvenile Idiopathic Arthritis (pJIA) and Juvenile Psoriatic Arthritis (PsA) Within the German Biologics in Pediatric Rheumatology Registry (BiKeR) and Juvenile Arthritis Methotrexate/Biologics Long-term Observation (JuMBO) Registries (BiKeRJuMBO)